ASTRO Names Richard Hoppe President-Elect

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 12
Volume 4
Issue 12

MIAMI BEACH--Richard Hoppe, MD, has been named president-elect of the American Society for Therapeutic Radiology and Oncology (ASTRO). Dr. Hoppe is chairman of the Department of Radiation Oncology at Stanford University School of Medicine. He will take office at the Society's annual meeting to be held in Los Angeles next October.

MIAMI BEACH--Richard Hoppe, MD, has been named president-electof the American Society for Therapeutic Radiology and Oncology(ASTRO). Dr. Hoppe is chairman of the Department of RadiationOncology at Stanford University School of Medicine. He will takeoffice at the Society's annual meeting to be held in Los Angelesnext October.

The current president, who took office at this year's ASTRO meeting,is Steven A. Leibel, MD, vice-chairman, clinical director, andEnid A. Haupt Chair, Department of Radiation Oncology, MemorialSloan-Kettering Cancer Center.

Other new officers announced at the meeting are: chairman of theboard, Jay R. Harris, MD, Joint Center for Radiation Therapy,Harvard Medical School; secretary, Karen K. Fu, MD, Universityof California, San Francisco, Mt. Zion Cancer Center; and treasurer,John D. Earle, MD, Mayo Medical School.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content